<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">Evidence of sex differences in COVID-19 severity emerged in China, where hospital admissions and mortality were higher among males than females
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>â€“
  <xref ref-type="bibr" rid="CR8">8</xref>
 </sup>. In South Korea, where community testing was widespread, females represented ~60% of those testing positive for SARS-CoV-2, suggesting that females acquire infection, despite having a lower case fatality rate (CFR)
 <sup>
  <xref ref-type="bibr" rid="CR9">9</xref>,
  <xref ref-type="bibr" rid="CR10">10</xref>
 </sup>. In the United States, where testing was prioritized for people with symptomatic disease, the diagnosis rates were similar in males and females, but males had 1.5 times higher mortality
 <sup>
  <xref ref-type="bibr" rid="CR11">11</xref>
 </sup>.
</p>
